Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Takeda’s HAE drug Takhzyro backed by NICE

Takeda’s HAE drug Takhzyro backed by NICE Like Firazyr and Cinryze, Takhzyro was originally developed by Shire, which has been absorbed by Takeda in a  $63bn takeover.

Takeda makes Crohn’s disease case for subcutaneous Entyvio

Takeda makes Crohn’s disease case for subcutaneous Entyvio Patent expiries and a weak near-term pipeline were the main drivers for Takeda's  $63bn takeover of Shire, which completed in January.

EMA clears Novo Nordisk’s long-acting haemophilia A drug

EMA clears Novo Nordisk’s long-acting haemophilia A drug Takeda’s Shire unit already has a long-acting factor VIII product on the market in Adynovate, as does Sanofi with Eloctate from its recent Bioverativ acquisition, Bayer with Kovaltry, and

Servier begins construction of new R&D hub in Paris

Servier begins construction of new R&D hub in Paris Last year it paid out $2.4bn to buy Shire’s oncology division, and opened up an office in Kendall Square in Boston, Massachusetts in order to tap into new science

Testimonials

With the integration of Shire into our UK &Ireland team we will continue to empower our people to be ambitious and change the game for patients, a key achievement of our

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics